In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
January 5th, 2010 | 23 | No |
Popular Name: (2S)-2-amino-2-[4-(4-octylphenyl)-1H-imidazol-2-yl]ethanol (2S)-2-amino-2-[4-(4-octylphenyl…
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.45 | 6.48 | -30.63 | 5 | 4 | 1 | 76 | 316.469 | 10 | ↓ |
Mid Mid (pH 6-8) | 2.45 | 5.82 | -6.05 | 4 | 4 | 0 | 75 | 315.461 | 10 | ↓ |
Mid Mid (pH 6-8) | 2.45 | 6.15 | -40.49 | 5 | 4 | 1 | 77 | 316.469 | 10 | ↓ |
Mid Mid (pH 6-8) | 2.45 | 6.81 | -112.69 | 6 | 4 | 2 | 78 | 317.477 | 10 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
S1PR1-1-E | Sphingosine 1-phosphate Receptor Edg-1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2700 | 0.34 | Binding ≤ 10μM |
S1PR3-1-E | Sphingosine 1-phosphate Receptor Edg-3 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2700 | 0.34 | Binding ≤ 10μM |
S1PR4-1-E | Sphingosine 1-phosphate Receptor Edg-6 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7400 | 0.31 | Binding ≤ 10μM |
S1PR5-1-E | Sphingosine 1-phosphate Receptor Edg-8 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 860 | 0.37 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
S1PR5_HUMAN | Q9H228 | Sphingosine 1-phosphate Receptor Edg-8, Human | 860 | 0.37 | Binding ≤ 1μM |
S1PR1_HUMAN | P21453 | Sphingosine 1-phosphate Receptor Edg-1, Human | 2700 | 0.34 | Binding ≤ 10μM |
S1PR3_HUMAN | Q99500 | Sphingosine 1-phosphate Receptor Edg-3, Human | 2700 | 0.34 | Binding ≤ 10μM |
S1PR4_HUMAN | O95977 | Sphingosine 1-phosphate Receptor Edg-6, Human | 7400 | 0.31 | Binding ≤ 10μM |
S1PR5_HUMAN | Q9H228 | Sphingosine 1-phosphate Receptor Edg-8, Human | 860 | 0.37 | Binding ≤ 10μM |
Description | Species |
---|---|
G alpha (i) signalling events | |
Lysosphingolipid and LPA receptors |